Back
Reitmans (Canada) Vs. Viking Therapeutics Industry Stock Comparison
Sell
38
RET.A.V
Reitmans (Canada)
Last Price:
2.35
Seasonality Move:
48.35%
Buy
54
VKTX
Viking Therapeutics
Last Price:
51.26
Seasonality Move:
6.26%
Sell
38
Reitmans (Canada) (RET.A.V)
is a Sell
Is Reitmans (Canada) a Buy, Sell or Hold?
- The current Reitmans (Canada) [RET.A.V] share price is $2.35. The Score for RET.A.V is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- RET.A.V is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Viking Therapeutics (VKTX)
is a Buy
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $51.27. The Score for VKTX is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- VKTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RET.A.V Stock Price Chart
What is Reitmans (Canada)'s stock price today?
-
The Reitmans (Canada) share price today is $2.35
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RET.A.V is experiencing slight buying pressure.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $51.27
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing slight selling pressure.
RET.A.V Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 41.8 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.34 - 2.44) | Sell |
| Bollinger Bands (100): | (2.38 - 2.52) | Sell |
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.92 | Sell |
| Relative Strength Index (14 RSI): | 42.17 | Sell |
| Chaikin Money Flow: | -7165 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (49.73 - 57.75) | Sell |
| Bollinger Bands (100): | (49.81 - 78.71) | Sell |
RET.A.V Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.38 | Sell |
| 20-day SMA: | 2.41 | Sell |
| 50-day SMA: | 2.41 | Sell |
| 200-day SMA: | 2.46 | Sell |
| 8-day EMA: | 2.38 | Sell |
| 20-day EMA: | 2.4 | Sell |
| 50-day EMA: | 2.42 | Sell |
| 200-day EMA: | 2.51 | Sell |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 50.94 | Buy |
| 20-day SMA: | 52.11 | Sell |
| 50-day SMA: | 62.69 | Sell |
| 200-day SMA: | 39.93 | Buy |
| 8-day EMA: | 51.54 | Sell |
| 20-day EMA: | 53.48 | Sell |
| 50-day EMA: | 58.29 | Sell |
| 200-day EMA: | 45.95 | Buy |
Reitmans (Canada) Earnings Growth & RET.A.V Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.06 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.43 per share.
Reitmans (Canada) Technical Analysis
| Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 2 | Jul 3 | Jul 4 | Jul 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 21 | 24 | 25 | 26 | 27 | 28 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Viking Therapeutics Technical Analysis
| Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | Jul 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||